Medtronic plc (0Y6X.L)
USD 83.71
(1.22%)
USD 83.71
(1.22%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 9.05 Billion USD | 10.33% |
| 2022 | 8.47 Billion USD | -7.72% |
| 2021 | 9.55 Billion USD | 10.07% |
| 2020 | 8.19 Billion USD | 7.16% |
| 2019 | 7.82 Billion USD | -22.72% |
| 2018 | 9.36 Billion USD | 5.04% |
| 2017 | 9.18 Billion USD | -2.1% |
| 2016 | 9.02 Billion USD | 6.22% |
| 2015 | 8.53 Billion USD | 42.29% |
| 2014 | 6.27 Billion USD | 11.21% |
| 2013 | 5.64 Billion USD | 0.93% |
| 2012 | 5.53 Billion USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 2.04 Billion USD | -18.01% |
| 2023 Q1 | 1.99 Billion USD | -16.37% |
| 2023 Q2 | 2.18 Billion USD | 9.54% |
| 2023 Q3 | 2.09 Billion USD | -3.94% |
| 2023 Q4 | 2.18 Billion USD | 4.06% |
| 2023 FY | - USD | 2.08% |
| 2022 Q3 | 1.95 Billion USD | -4.41% |
| 2022 Q4 | 2.38 Billion USD | 22.03% |
| 2022 Q1 | 1.73 Billion USD | -27.51% |
| 2022 Q2 | 2.04 Billion USD | 17.42% |
| 2022 FY | - USD | -7.72% |
| 2021 Q1 | 1.64 Billion USD | -35.26% |
| 2021 FY | - USD | 10.07% |
| 2021 Q2 | 2.33 Billion USD | 41.54% |
| 2021 Q3 | 2.45 Billion USD | 5.23% |
| 2021 Q4 | 2.39 Billion USD | -2.32% |
| 2020 Q2 | 1.84 Billion USD | 37.48% |
| 2020 FY | - USD | 7.16% |
| 2020 Q1 | 1.34 Billion USD | 33.0% |
| 2020 Q3 | 2.3 Billion USD | 25.04% |
| 2020 Q4 | 2.54 Billion USD | 10.4% |
| 2019 Q2 | 2.21 Billion USD | -2.73% |
| 2019 FY | - USD | -22.72% |
| 2019 Q4 | 1 Billion USD | -58.7% |
| 2019 Q3 | 2.44 Billion USD | 10.49% |
| 2019 Q1 | 2.27 Billion USD | -18.27% |
| 2018 Q2 | 2.19 Billion USD | 5.42% |
| 2018 Q4 | 2.78 Billion USD | 17.34% |
| 2018 Q3 | 2.37 Billion USD | 7.92% |
| 2018 Q1 | 2.08 Billion USD | -26.34% |
| 2018 FY | - USD | 5.04% |
| 2017 Q1 | 2.08 Billion USD | -16.41% |
| 2017 FY | - USD | -2.1% |
| 2017 Q3 | 2.44 Billion USD | 23.97% |
| 2017 Q4 | 2.82 Billion USD | 15.62% |
| 2017 Q2 | 1.97 Billion USD | -5.55% |
| 2016 Q1 | 2.13 Billion USD | -16.54% |
| 2016 FY | - USD | 6.22% |
| 2016 Q4 | 2.49 Billion USD | 15.91% |
| 2016 Q3 | 2.15 Billion USD | -3.92% |
| 2016 Q2 | 2.24 Billion USD | 5.15% |
| 2015 Q3 | 2.02 Billion USD | -1.85% |
| 2015 FY | - USD | 42.29% |
| 2015 Q1 | 2.11 Billion USD | -1.68% |
| 2015 Q2 | 2.05 Billion USD | -2.6% |
| 2015 Q4 | 2.55 Billion USD | 26.58% |
| 2014 Q2 | 1.4 Billion USD | 0.21% |
| 2014 FY | - USD | 11.21% |
| 2014 Q4 | 2.14 Billion USD | 56.86% |
| 2014 Q3 | 1.37 Billion USD | -2.63% |
| 2014 Q1 | 1.4 Billion USD | -12.8% |
| 2013 Q4 | 1.61 Billion USD | 17.18% |
| 2013 Q2 | 1.37 Billion USD | 1.93% |
| 2013 Q1 | 1.34 Billion USD | -13.78% |
| 2013 Q3 | 1.37 Billion USD | 0.22% |
| 2013 FY | - USD | 0.93% |
| 2012 Q4 | 1.56 Billion USD | 15.73% |
| 2012 FY | - USD | 0.0% |
| 2012 Q3 | 1.34 Billion USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Phreesia, Inc. | -102.94 Million USD | 8896.93% |
| Accuray Incorporated | 9 Million USD | -100421.701% |
| Align Technology, Inc. | 799.03 Million USD | -1033.361% |
| Elevance Health Inc. | 10.49 Billion USD | 13.67% |
| AxoGen, Inc. | -13.32 Million USD | 68047.179% |
| Boston Scientific Corporation | 3.61 Billion USD | -150.65% |
| CVS Health Corporation | 18.17 Billion USD | 50.182% |
| Cardinal Health, Inc. | 1.97 Billion USD | -357.836% |
| Centene Corporation | -463 Million USD | 2055.94% |
| DaVita Inc. | 2.34 Billion USD | -285.945% |
| HCA Healthcare, Inc. | 12.72 Billion USD | 28.811% |
| Hologic, Inc. | 1.29 Billion USD | -598.658% |
| Humana Inc. | -561 Million USD | 1714.26% |
| IDEXX Laboratories, Inc. | 1.21 Billion USD | -643.719% |
| Laboratory Corporation of America Holdings | 1.34 Billion USD | -571.113% |
| Masimo Corporation | 236.7 Million USD | -3725.94% |
| McKesson Corporation | 4.66 Billion USD | -94.043% |
| Patterson Companies, Inc. | 374.75 Million USD | -2316.506% |
| Quest Diagnostics Incorporated | 1.73 Billion USD | -422.864% |
| ResMed Inc. | 1.6 Billion USD | -465.883% |
| Henry Schein, Inc. | 943 Million USD | -860.339% |
| Teladoc Health, Inc. | 153.99 Million USD | -5780.634% |
| Universal Health Services, Inc. | 1.74 Billion USD | -419.438% |
| Veeva Systems Inc. | 429.33 Million USD | -2009.313% |
| Baxter International Inc. | 2.77 Billion USD | -226.225% |
| Becton, Dickinson and Company | 4.27 Billion USD | -111.836% |
| Intuitive Surgical, Inc. | 2.39 Billion USD | -278.263% |
| Danaher Corporation | 7.49 Billion USD | -20.763% |
| Stryker Corporation | 5.16 Billion USD | -75.504% |